Skip to main content

Profund Advisors LLC

SEC CIK
0001129919
Latest filing
Aug 11, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
23,398
Value
$11.6M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Profund Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202623,398$11.6M0.3%+261+1.1%AddedHolders
Q1 202623,137$10.3M0.4%−5,681−19.7%ReducedHolders
Q4 202528,818$13.1M0.4%+2,423+9.2%AddedHolders
Q3 202526,395$10.3M0.3%−958−3.5%ReducedHolders
Q2 202527,353$12.2M0.4%+2,682+10.9%AddedHolders
Q1 202524,671$12.0M0.5%−3,903−13.7%ReducedHolders
Q4 202428,574$11.5M0.4%+654+2.3%AddedHolders
Q3 202427,920$13.0M0.5%−1,626−5.5%ReducedHolders
Q2 202429,546$13.8M0.5%+3,194+12.1%AddedHolders
Q1 202426,352$11.0M0.4%−1,730−6.2%ReducedHolders
Q4 202328,082$11.4M0.5%+3,495+14.2%AddedHolders
Q3 202324,587$8.55M0.5%+4,653+23.3%AddedHolders
Q2 202319,934$7.01M0.4%+967+5.1%AddedHolders
Q1 202318,967$5.98M0.4%−22,299−54.0%ReducedHolders
Q4 202241,266$11.9M0.8%−180.0%ReducedHolders
Q3 202241,284$12.0M0.9%−2,018−4.7%ReducedHolders
Q2 202243,302$12.2M0.8%−5,796−11.8%ReducedHolders
Q1 202249,098$12.8M0.5%−9,510−16.2%ReducedHolders
Q4 202158,608$12.9M0.4%−8,612−12.8%ReducedHolders
Q3 202167,220$12.2M0.4%+37+0.1%AddedHolders
Q2 202167,183$13.5M0.5%−2,206−3.2%ReducedHolders
Q1 202169,389$14.9M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.